| Literature DB >> 16640343 |
Daren Stephens1, Efrosini Barbayianni, Violetta Constantinou-Kokotou, Anna Peristeraki, David A Six, Jennifer Cooper, Richard Harkewicz, Raymond A Deems, Edward A Dennis, George Kokotos.
Abstract
Inhibitors of the Group IVA phospholipase A(2) (GIVA cPLA(2)) and GVIA iPLA(2) are useful tools for defining the roles of these enzymes in cellular signaling and inflammation. We have developed inhibitors of GVIA iPLA(2) building upon the 2-oxoamide backbone that are uncharged, containing ester groups. Although the most potent inhibitors of GVIA iPLA(2) also inhibited GIVA cPLA(2), there were three 2-oxoamide compounds that selectively and weakly inhibited GVIA iPLA(2). We further show that several potent 2-oxoamide inhibitors of GIVA cPLA(2) containing free carboxylic groups (Kokotos et al. J. Med. Chem. 2002, 45, 2891-2893) do not inhibit GVIA iPLA(2) and are, therefore, selective GIVA cPLA(2) inhibitors.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16640343 PMCID: PMC2544624 DOI: 10.1021/jm050993h
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446